Regeneron Pharmaceuticals, Inc - Strategy, SWOT and Corporate Finance Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $175	73 Pages	MarketLine	January, 2022	MTLN17000041

Attention: There is an updated edition available for this report.

Best Price Guarantee
Price	from $175
Length	73 Pages
Publisher	MarketLine
Published Date	January, 2022
SKU	MTLN17000041

Regeneron Pharmaceuticals, Inc - Strategy, SWOT and Corporate Finance Report

Summary

Regeneron Pharmaceuticals, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Regeneron Pharmaceuticals, Inc. (Regeneron or 'the company') discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The company offer drugs for patients with cancer, eye diseases, cardiovascular and metabolic diseases, allergic and inflammatory diseases, infectious diseases, neuromuscular diseases, rare diseases and asthma. Its major drugs include Dupixent injection, Eylea injection, Arcalyst injection, Praluent injection, Libtayo Injection, Zaltrapinjection and Kevzara injection. Regeneron sells its products to various distributors and specialty pharmacies in the US. It operates manufacturing facilities in Limerick, Ireland and Rensselaer, New York, the US. The company is headquartered in Tarrytown, New York, the US

Scope

Detailed information on Regeneron Pharmaceuticals, Inc required for business and competitor intelligence needs
A study of the major internal and external factors affecting Regeneron Pharmaceuticals, Inc in the form of a SWOT analysis
An in-depth view of the business model of Regeneron Pharmaceuticals, Inc including a breakdown and examination of key business segments
Intelligence on Regeneron Pharmaceuticals, Inc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Regeneron Pharmaceuticals, Inc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Regeneron Pharmaceuticals, Inc and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Regeneron Pharmaceuticals, Inc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Regeneron Pharmaceuticals, Inc's business structure, strategy and prospects.

Company Snapshot: Regeneron Pharmaceuticals, Inc.: Company Overview; Regeneron Pharmaceuticals, Inc.: Overview and Key Facts; Regeneron Pharmaceuticals, Inc.: Overview; Regeneron Pharmaceuticals, Inc.: Key Facts; Regeneron Pharmaceuticals, Inc.: Key Employees; Regeneron Pharmaceuticals, Inc.: Key Employee Biographies; Regeneron Pharmaceuticals, Inc.: Major Products and Services; Regeneron Pharmaceuticals, Inc.: Company History; Regeneron Pharmaceuticals, Inc.: Management Statement; Regeneron Pharmaceuticals, Inc.: Locations and Subsidiaries; Regeneron Pharmaceuticals, Inc.: Key Competitors; Regeneron Pharmaceuticals, Inc.: Company Analysis; Regeneron Pharmaceuticals, Inc.: Business Description; Regeneron Pharmaceuticals, Inc.: SWOT Analysis; Regeneron Pharmaceuticals, Inc.: SWOT Overview; Regeneron Pharmaceuticals, Inc.: Strengths; Regeneron Pharmaceuticals, Inc.: Weaknesses; Regeneron Pharmaceuticals, Inc.: Opportunities; Regeneron Pharmaceuticals, Inc.: Threats; Regeneron Pharmaceuticals, Inc.: Corporate Financial Deals Activity; Regeneron Pharmaceuticals, Inc.: Financial Deals Overview; Regeneron Pharmaceuticals, Inc.: Targets and Partners; Regeneron Pharmaceuticals, Inc.: Top Deals 2018 - 2022YTD*; Regeneron Pharmaceuticals, Inc.: Advisors; Regeneron Pharmaceuticals, Inc.: Top Legal Advisors; Regeneron Pharmaceuticals, Inc.: Top Financial Advisors; Regeneron Pharmaceuticals, Inc.: Mergers and Acquisitions; Regeneron Pharmaceuticals, Inc.: Corporate Venturing; Regeneron Pharmaceuticals, Inc.: Capital Raising; Regeneron Pharmaceuticals, Inc.: Partnership; Regeneron Pharmaceuticals, Inc.: Recent Developments; Regeneron Pharmaceuticals, Inc.: News and Events Summary; Regeneron Pharmaceuticals, Inc.: Corporate Governance; Regeneron Pharmaceuticals, Inc.: Financial Deals; Regeneron Pharmaceuticals, Inc.: Financial Performance; Regeneron Pharmaceuticals, Inc.: Grants; Regeneron Pharmaceuticals, Inc.: Regulatory and Legal Events; Regeneron Pharmaceuticals, Inc.: Research & Development; Regeneron Pharmaceuticals, Inc.: Strategy and Operations
Appendix: Contact Us; Methodology; About MarketLine
List of Tables: Table 1: Regeneron Pharmaceuticals, Inc.: Key Facts; Table 2: Regeneron Pharmaceuticals, Inc.: Key Employees; Table 3: Regeneron Pharmaceuticals, Inc.: Company History; Table 4: Regeneron Pharmaceuticals, Inc.: Locations and Subsidiaries; Table 5: Regeneron Pharmaceuticals, Inc.: Key Competitors; Table 6: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*); Table 7: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022); Table 8: Regeneron Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m); Table 9: Regeneron Pharmaceuticals, Inc.: Targets and Partners; Table 10: Regeneron Pharmaceuticals, Inc.: Top Deals 2018 - 2022YTD*; Table 11: Regeneron Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m); Table 12: Regeneron Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m); Table 13: Regeneron Pharmaceuticals, Inc.: M&A Volume and Value Trend (2018 - YTD*2022); Table 14: Regeneron Pharmaceuticals, Inc.: M&A Activity by Geography (2018 - YTD*2022); Table 15: Regeneron Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022); Table 16: Regeneron Pharmaceuticals, Inc.: Corporate Venturing by Geography (2018 - YTD*2022); Table 17: Regeneron Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022); Table 18: Regeneron Pharmaceuticals, Inc.: Capital Raising by Deal Type (2018 - YTD*2022); Table 19: Regeneron Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022); Table 20: Regeneron Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022); Table 21: Regeneron Pharmaceuticals, Inc.: News and Events Summary; Table 22: Regeneron Pharmaceuticals, Inc.: Corporate Governance; Table 23: Regeneron Pharmaceuticals, Inc.: Financial Deals; Table 24: Regeneron Pharmaceuticals, Inc.: Financial Performance; Table 25: Regeneron Pharmaceuticals, Inc.: Grants; Table 26: Regeneron Pharmaceuticals, Inc.: Regulatory and Legal Events; Table 27: Regeneron Pharmaceuticals, Inc.: Research & Development; Table 28: Regeneron Pharmaceuticals, Inc.: Strategy and Operations
List of Figures: Figure 1: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*); Figure 2: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022); Figure 3: Regeneron Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m); Figure 4: Regeneron Pharmaceuticals, Inc.: M&A Volume and Value Trend (2018 - YTD*2022); Figure 5: Regeneron Pharmaceuticals, Inc.: M&A Activity by Geography (2018 - YTD*2022); Figure 6: Regeneron Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022); Figure 7: Regeneron Pharmaceuticals, Inc.: Corporate Venturing by Geography (2018 - YTD*2022); Figure 8: Regeneron Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022); Figure 9: Regeneron Pharmaceuticals, Inc.: Capital Raising by Deal Type (2018 - YTD*2022); Figure 10: Regeneron Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022); Figure 11: Regeneron Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)